3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Breast
1
Conditions
Pancreatic Neoplasms
3
Stomach Neoplasms
2
Breast Neoplasms
2
Vaginal Neoplasms
1
Uterine Neoplasms
1
Uterine Cervical Neoplasms
1
Urinary Bladder Neoplasms
1
Thyroid Neoplasms
1
Testicular Neoplasms
1
Solitary Fibrous Tumors
1
Sarcoma
1
Salivary Gland Neoplasms
1
Prostatic Neoplasms
1
Penile Neoplasms
1
Pancreatic Ductal Adenocarcinoma (PDAC)
1
Ovarian Neoplasms
1
Neuroendocrine Tumors
1
Lung Neoplasms
1
Esophageal Neoplasms
1
Colorectal Neoplasms
1
Cholangiocarcinoma
1
Carcinoma, Transitional Cell
1
Carcinoma, Ovarian Epithelial
1
Carcinoma, Medullary
1
Carcinoma, Intraductal, Noninfiltrating
1
Carcinoma, Hepatocellular
1
Brain Neoplasms
1
Bile Duct Neoplasms
1
Anus Neoplasms
1
Adrenal Gland Neoplasms
1
Interventions
Tamoxifen
6
Specimen Handling
6
Anastrozole
3
exemestane
2
Surveys and Questionnaires
2
Radiosurgery
2
Letrozole
2
Genetic Testing
2
Biopsy
2
poly ICLC
1
elacestrant
1
Testosterone
1
Standard of Care
1
Sentinel Lymph Node Biopsy
1
Selective Estrogen Receptor Modulators
1
Restraint, Physical
1
Radiotherapy
1
Practice Guidelines as Topic
1
Patient Navigation
1
Omacor
1
Multicenter Studies as Topic
1
Methods
1
Meditation
1
Medicare
1
Mastectomy, Segmental
1
Mastectomy
1
Granulocyte-Macrophage Colony-Stimulating Factor
1
Genetic Counseling
1
Follow-Up Studies
1
FAPI-46
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Recruiting
×
Carcinoma, Intraductal, Noninfiltrating
×
FAPI-46
×
Clear all
NCT06540872
2026-06-03
MI-CISDIR
Universität Münster
Phase 2
Recruiting
30 enrolled